These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Teschke R; Danan G Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400 [No Abstract] [Full Text] [Related]
15. An update on drug induced liver injury. Rangnekar AS; Fontana RJ Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150 [TBL] [Abstract][Full Text] [Related]
17. The LiverTox Paradox-Gaps between Promised Data and Reality Check. Teschke R; Danan G Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679453 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury. Benesic A; Rotter I; Dragoi D; Weber S; Leitl A; Buchholtz ML; Gerbes AL Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1488-1494.e5. PubMed ID: 29723689 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced liver injury in the Australian setting. Sistanizad M; Peterson GM J Clin Pharm Ther; 2013 Apr; 38(2):115-20. PubMed ID: 23350857 [TBL] [Abstract][Full Text] [Related]
20. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]